Beyond APIs, most of a pharmaceutical manufacturer's raw material spend goes toward a less headline-grabbing but equally critical category: intermediates, specialty chemicals, solvents, and formulations. Get these wrong and the consequences range from a failed batch to a residual solvent limit breach that stops a product at regulatory review. This guide covers what buyers need to know when sourcing across this category, and how to vet a supplier properly.
Intermediates, Specialty Chemicals, Solvents & Formulations: What's the Difference?
These four terms are often used loosely, but they mean distinct things in a procurement context:
- Intermediates: Compounds produced partway through the synthesis of an API, including Key Starting Materials (KSMs) - the building blocks a manufacturer combines through further chemical steps to arrive at the finished active ingredient.
- Specialty chemicals: Fine chemicals, reagents, and performance compounds used within the manufacturing process itself - catalysts, reagents, and process aids that do not appear in the final drug product but are essential to producing it.
- Solvents: Liquids used to dissolve, extract, or facilitate chemical reactions during synthesis and formulation. Because solvent residues can remain in the finished product, they are separately regulated for toxicological limits.
- Formulations: Finished pharmaceutical dosage forms - tablets, capsules, injectables, oral liquids, and topicals - manufactured from APIs and excipients under full GMP conditions.
Why Sourcing This Category Is Different from APIs
Sourcing an API is typically a narrow, high-scrutiny search for one specific molecule against a pharmacopoeial monograph. Sourcing intermediates, specialty chemicals, and solvents is broader and more variable: a buyer might need dozens of different compounds across a formulation's production line, each with its own grade, purity specification, and supplier landscape. That breadth is exactly where an indenting house adds the most value - managing many supplier relationships and specifications in parallel is a different operational problem than managing one.
ICH Q3C and Why Solvent Classification Matters
Pharmaceutical solvents are governed by ICH Q3C, the international guideline classifying residual solvents by toxicological risk:
- Class I: Solvents to be avoided - known or suspected human carcinogens, or environmentally hazardous.
- Class II: Solvents to be limited - associated with less severe toxicity, permitted up to defined concentration limits (for example, acetonitrile, methanol, toluene).
- Class III: Solvents with low toxicological risk - permitted at higher limits or without a specific numeric limit (for example, ethanol, ethyl acetate, IPA).
Buyers sourcing solvents such as methanol, ethanol, IPA, n-butanol, ethyl acetate, DMF, DMSO, NMP, MEK, or toluene need to confirm both the ICH Q3C class and the purity grade (pharma-grade vs. industrial-grade) before a solvent is approved for GMP manufacturing use. Using the wrong grade, even at the right chemical purity, can trigger a compliance failure at product review.
The Sourcing Process
A disciplined sourcing process for this category runs through eight steps:
- Global supplier identification & vetting
- Technical specification review
- Price benchmarking & negotiation
- Sample coordination & tracking
- Purchase order management
- Logistics & freight coordination
- Import documentation & customs
- After-shipment follow-up & QC
Skipping any of these steps shifts risk onto the buyer. Sample coordination in particular is where many buyers cut corners - approving a supplier off a Certificate of Analysis alone, without an independent sample verification, is a common source of later batch failures.
Common Buyer Mistakes
- Treating "food-grade" or "technical-grade" as equivalent to pharma-grade. The chemical formula may be identical, but impurity profiles and documentation differ.
- Not confirming ICH Q3C class before approving a solvent for GMP use. This is caught late, often at product registration, if not checked at sourcing stage.
- Single-sourcing a critical intermediate. A supply disruption at one manufacturer can stall an entire production line with no qualified backup.
- Skipping sample verification to save time. A CoA reflects one batch; independent verification confirms the supplier consistently meets specification.
How Sumsahi Kemicals' Indenting Model Helps
As a full-service chemical sourcing and indenting house, Sumsahi Kemicals acts as your representative in the global market for this entire category - currently listing 90 intermediates, 77 specialty chemicals, 41 pharma-grade solvents (ICH Q3C Class II/III), and 60 finished formulations, sourced from India, China, Germany, Russia, South Korea, Japan, Taiwan, UAE, Bangladesh, Sri Lanka, Latin America and Canada. We identify and vet suppliers, review technical specifications against your requirement, benchmark pricing, coordinate samples, manage the purchase order and logistics, and follow up on quality after shipment - so you get one point of accountability across a category that would otherwise mean managing dozens of separate supplier relationships.